Cummings J

ORCID: 0000-0001-8944-4158 · 1 paper in corpus · active 2020
2020
Repurposed agents in the Alzheimer's disease drug development pipeline.
Alzheimer's research & therapy ·doi:10.1186/s13195-020-00662-x

BackgroundTreatments are needed to address the growing prevalence of Alzheimer's disease (AD). Clinical trials have failed to produce any AD drugs for Food and Drug Administration (FDA) approval since 2003, and the pharmaceutical developmen…